A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety

Journal of Clinical Psychiatry

Volumn 59, Issue 3, 1998, Pages 123-127

  Fawcett, Jan ^a,b   Barkin, Robert L ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; BUSPIRONE; CLONIDINE; DESIPRAMINE; FLUOXETINE; HYDROXYZINE; IMIPRAMINE; MIRTAZAPINE; PAROXETINE; PHENELZINE; PLACEBO; TRAZODONE; VENLAFAXINE;

ADULT; AGED; AGITATION; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SOMATIZATION;

EID: 0031900040     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v59n0306     Document Type: Article

References (26)

1. Goldberg RJ. Diagnostic dilemmas presented by patients with anxiety and depression. Am J Med 1995;98:278-284
2. Kravitz HM, Fogg L, Fawcett J, et al. Antidepressant or anxiety? a study of the efficacy of antidepressant medication. Psychiatry Res 1990;32: 141-149
3. Stein MB, Uhde TW. Panic disorder and major depression: a tale of two syndromes. Psychiatr Clin North Am 1988;11:441-461
4. Fawcett J, Kravitz M. Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 1983;44(8, sec 2):8-11
5. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. Am J Psychiatry 1991;148:1512-1517
6. Fawcett J. Predictors of early suicide: identification and appropriate intervention. J Clin Psychiatry 1988;49(10, suppl):7-8
7. Fawcett J, Scheftner WA, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990;147:1189-1194
8. Fawcett J, Busch KA. The psychobiology of suicide. Clin Neurosci 1993; 1:101-107
9. Coplan JD, Gorman JM. Treatment of anxiety disorder in patients with mood disorders. J Clin Psychiatry 1990;51(10, suppl):9-13
10. Barkin RL, Lubenow TR, Bruehl S, et al. Management of chronic pain, I. Dis Mon 1996;42:389-454
11. Pohl R, Yeragani VK, Balon R, et al. The jitteriness syndrome in panic disorder patients treated with antidepressants. J Clin Psychiatry 1988;49: 100-104
12. Wishing WC, Van Patten T, Rosenberg J, et al. Fluoxetine, akathisia, and suicidality: is there a connection? Arch Gen Psychiatry 1992;49:580-581
13. 3 postreceptor antagonist for the treatment of major depression. J Affect Disord. In press
14. 1A-mediated serotonergic neurotransmission. CNS Drugs 1995;4(suppl 1):29-38
15. de Boer T, Maura G, Raiteri M, et al. Neurochemical and autonomie pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology 1988;27:399-408
16. Kao L, Barkin RL, Leikin J. Mirtazapine overdose: a case report. In: Medical Update for Psychiatrists. New York, NY: Elsevier Science; 1997; 22:58-59
17. Bremner JD. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression. J Clin Psychiatry 1995;56:519-525
18. Claghorn JL, Lesem MD. A double-blind placebo-controlled study of Org 3770 in depressed outpatients. J Affect Disord 1995;34:165-171
19. Halikas JA. Org 3770 (mirtazapine) versus trazodone: a placebo controlled trial in depressed elderly patients. Hum Psychopharmacol 1995;10: S125-S133
20. Smith WT, Glaudin V, Panagides J, et al. Mirtazapine vs amitriptyline vs placebo in the treatment of major depressive disorder. Psychopharmacol Bull 1990;26:191-196
21. Jacobsen AF, Dominquez RA. Comparison of Org 3770 and amitriptyline in depressed patients [Abstract 83]. J Clin Psychopharmacol 1990;30:851
22. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
23. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
24. Remeron. Physicians' Desk Reference. Montvale. NJ: Medical Economics Company; 1998:1956-1959
25. Bone RC, Hayden WR, Levine RL, et al. Recognition assessment, and treatments of anxiety in the critical care patient. Dis Mon 1996;41(5): 293-354
26. Fawcett J. Targeting treatment in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 1990;5:(11, suppl):40-43